Clinical Trial Update: Physiologic Assessment Following Gadoxetic Acid and Gadobenate Dimeglumine Administration

View source ↗

Summary

This document reports a completed clinical trial evaluating physiologic responses after administration of two MRI contrast agents, gadoxetic acid and gadobenate…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Cancer

Drugs mentioned

• Gadobenate dimeglumine (gadobenate dimeglumine)
• Gadoxetic acid (Eovist/Primovist) (gadoxetic acid disodium)

Snippet

Sponsor: University of Michigan | Conditions: Liver Tumor | Status: COMPLETED